Non-V600 mutations comprise approximately 35% of all BRAF mutations in cancer. Many of these mutations have been identified as oncogenic drivers and can be classified into three classes according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback